Frontier Science

An analysis of the challenges and strategies for scaling deep science ventures, focusing on the translation of frontier research into scalable industries through innovation ecosystems.

An analysis of how artificial intelligence is reshaping strategic value creation across various sectors, with specific implications for biotechnology, including drug discovery, biomanufacturing, and digital health.

A new Rhodium Group assessment for the U.S. Chamber of Commerce finds China's industrial strategy expanding across supply chains and frontier technologies. This analysis examines what the shift means for biotechnology, drug development, biomanufacturing, and global biomedical competitiveness.

A Rhodium Group assessment examines how Beijing's expanding state-directed industrial strategy is reshaping global supply chains and frontier technology competition, with notable consequences for biopharma, biomedicine, and biomedical innovation.

An analysis of how China's expanding industrial policy framework is reshaping the biotechnology sector, based on new research from Rhodium Group.

An evidence-based analysis of the key technological, demographic, and globalization trends reshaping the global biotechnology business environment, and the strategic responses that can position life sciences organizations for long-term success.